In vivo, the deregulation of LAIR1 leads to an increase in uncontrolled inflammation, as well as its hyperregulation in some types of cancer, which has been associated with disease progression and may act as a predictor of clinical outcomes. This evidence concerns the gene LAIR1 and cancer.